Conagra Brands Inc (Conagra) is a manufacturer, distributor, and marketer of consumer-packaged food products. It offers products under Birds Eye, Duncan Hines, Healthy Choice, Marie Callender’s, Reddi-wip, Slim Jim, and Angie’s Boomchickapop brand names. Conagra Brands serves a range of customers, including chain, wholesale, value, cooperative, club, and independent grocery stores, as well as foodservice customers such as restaurants, bars, schools, and healthcare facilities. Its products are also available online through various e-commerce platforms and retailers.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Conagra is leveraging advanced analytics and transformative technology to contemporize products and drive superior innovation across its business. The company fosters a culture of innovation through collaboration among diverse teams, which helps in developing new products, applying modern marketing strategies, enhancing digitization across the supply chain, and delivering growth. The company's product development strategy involves studying forces that shape food behaviors, identifying the right brands within its portfolio to support these drivers, and constantly challenging itself to offer new products within existing categories and beyond. The innovation model is designed for ongoing success across its portfolio of iconic and emerging brands. In FY2025, the company incurred expenses of US$60.8 million on its R&D activities, which as a percentage of revenue, stood at 0.5%.